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Genome-wide erasure of DNA methylation takes
place in primordial germ cells (PGCs) and early
embryos and is linked with pluripotency. Inhibition
of Erk1/2 and Gsk3b signaling in mouse embryonic
stemcells (ESCs) by small-molecule inhibitors (called
2i) has recently been shown to induce hypomethy-
lation. We show by whole-genome bisulphite
sequencing that 2i induces rapid and genome-wide
demethylation on a scale and pattern similar to that
in migratory PGCs and early embryos. Major satel-
lites, intracisternal A particles (IAPs), and imprinted
genes remain relatively resistant to erasure. Deme-
thylation involves oxidation of 5-methylcytosine
(5mC) to 5-hydroxymethylcytosine (5hmC), impaired
maintenance of 5mC and 5hmC, and repression
of the de novo methyltransferases (Dnmt3a and
Dnmt3b) and Dnmt3L. We identify a Prdm14- and
Nanog-binding cis-acting regulatory region in
Dnmt3b that is highly responsive to signaling. These
insights provide a framework for understanding how
signaling pathways regulate reprogramming to an
epigenetic ground state of pluripotency.
INTRODUCTION
Acquisition of pluripotency in primordial germ cells (PGCs) and
the early embryo coincides with genome-wide epigenetic
reprogramming of histone modifications and DNA methylation,
but the precise relationship between reprogramming and
pluripotency is not clear (Seisenberger et al., 2013). Epigenetic
reprogramming in PGCs may be induced by signaling pathwaysCell Ssuch as BMP/Smad (Seisenberger et al., 2013), while FGF
signaling in the blastocyst is connected with the exit from plurip-
otency and epigenetic priming for differentiation (Lanner and
Rossant, 2010). It is not well understood how signaling pathways
maintain pluripotency in the inner cell mass (ICM), but a distinc-
tive feature of ICM cells is the lack of FGFR2, the earliest func-
tional receptor for FGF4 (reviewed in Lanner and Rossant,
2010). While global erasure of DNA methylation is closely
associated with the pluripotent state in PGCs (Seisenberger
et al., 2012; Hackett et al., 2013), it appears paradoxical that
ICM cells are also globally hypomethylated but ESCs resemble
somatic cells in their overall high levels of CpG methylation
(Stadler et al., 2011; Smith et al., 2012; Popp et al., 2010).
ESCs under standard culture conditions (in fetal calf serum
with LIF) receive prodifferentiation signals but are constrained
from differentiating by LIF. They have high levels of de novo
methyltransferases (Dnmt3a and Dnmt3b), their regulator
Dnmt3L, and the hydroxylases Tet1 and Tet2, suggesting con-
tinuous reprogramming of their epigenome (Ficz et al., 2011).
Because serum cultured ESCs are primed for differentiation by
Fgf/Erk, we reasoned that inhibition of this signaling pathway
by specific Erk1/2 and Gsk3b inhibitors (2i, Figure 1A) could
induce reprogramming to an ICM- or PGC-like epigenetic state.
Indeed, work recently published supports this contention by
showing that 2i can induce global hypomethylation (asmeasured
by mass spectrometry and at some selected loci in the genome),
that the de novo methyltransferases Dnmt3a and Dnmt3b and
their regulator Dnmt3L are downregulated in 2i, and that the
transcriptional regulator PRDM14 contributes to downregulation
of the Dnmt3s and to the maintenance of ESCs in the hypo-
methylated state (Yamaji et al., 2013; Leitch et al., 2013). The
genomic patterns and dynamics, as well as the mechanisms of
genome-wide demethylation induced by 2i, remain unknown,
and so does the question of whether the extent, patterns, and
mechanisms of demethylation occurring in 2i resemble those in
preimplantation embryos and PGCs (Seisenberger et al., 2013).tem Cell 13, 351–359, September 5, 2013 ª2013 The Authors 351
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Figure 1. Erk1/2 and Gsk3b Signal Inhibition
Induces Global DNA Demethylation
(A) Schematic of the signaling pathways inhibited
by the ‘‘2i’’ small molecule inhibitors.
(B) Global CpG methylation measured by whole-
genome BS-seq in serum, 2i, and E9.5 PGCs (data
from Seisenberger et al., 2012). Error bars repre-
sent the standard deviation in three replicates.
(C) Immunofluorescence staining of E14 ESCswith
an antibody against 5mC shows reduced euchro-
matic methylation in 2i while pericentromeric het-
erochromatic regions maintain high 5mC levels.
(D) Example of BS-seq profile in serum (black bars)
and 2i (purple bars) ESCs with the Nanog locus
being strongly demethylated in 2i while the ICR
methylation at Kcnq1ot1 is maintained.
(E) Heatmap methylation levels in 500 randomly
selected elements (CpG islands (CGIs), Exons,
Introns, LINE1, SINE) in Day 0, Day 24 Serum, and
Day 24 2i.
(F) Confirming IF data, methylation at pericentro-
meric major satellites remains high in 2i as
measured by BS-seq (error bars represent the
standard deviation between CpGs).
(G) Heatmap methylation levels in 500 randomly
selected IAP elements and 15 ICRs.
See also Figure S1.
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Epigenome of Ground State ESCs
To address these questions we carried out genome-wide bisul-
phite sequencing (BS-seq) and transcriptomics (RNA-seq),
comparing ESCs either grown in serum or switched from serum
to 2i conditions for 24 days. 2i induced a striking loss of DNA352 Cell Stem Cell 13, 351–359, September 5, 2013 ª2013 The Authorsmethylation as evaluated by BS-seq
(three biological replicates were se-
quenced for each experimental sample),
immunofluorescence, and mass spec-
trometry (Figures 1B and 1C and
Figure 3A); demethylation in 2i was wide-
spread as judged by pairwise individual
CpGmethylation comparison (Figure S1A
available online) and at its maximum re-
sulted in over 95% demethylation. BS-
seq showed that this loss of methylation
was similar in magnitude to the global
methylation erasure that occurs in migra-
tory PGCs prior to their gonadal stage
(Figure 1B) (Seisenberger et al., 2012).
Substantial demethylation occurred in
most genomic contexts, including gene
bodies (Figures 1D and 1E), non-CpG
island (non-CGI) promoters that are sub-
stantially methylated in serum ESCs,
and the SINE and LINE1 transposon fam-
ilies (Figure 1E). While there was some
erosion of methylation in major satellites,
intracisternal A particles (IAPs), and
imprinting control regions (ICRs), they
remained ultimately resistant to erasure(Figures 1D, 1F, and 1G, Figure 3B, Figure S2). This pattern of
demethylation closely resembles that of reprogramming in the
preimplantation embryo, with demethylation of LINE1 retrotrans-
posons and single copy genes such as Nanog, maintenance of
IAP and ICR methylation (Tomizawa et al., 2011), and detectable
pericentromeric heterochromatin methylation (methylation in
major satellites) in ICM cells (Santos et al., 2002). Notably, this
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their migration phase (Seisenberger et al., 2012), while ICRs
and germline-specific genes are demethylated upon their arrival
in the gonads (Seisenberger et al., 2012; Guibert et al., 2012; Haj-
kova et al., 2002). As in PGCs, global demethylation in 2i did not
result in promiscuous transcription of demethylated genes (Fig-
ure 2A). Indeed, a substantial number of genes in serum cultured
ESCs have promoters that are highly methylated with the major-
ity of them being transcriptionally silenced (blue group of pro-
moters in Figure 2A); while these promoters are demethylated
in 2i, this does not result in upregulation of the associated genes.
Rapid Dnmt3b Transcriptional Changes Are Effected
through a 2i-Responsive cis-Element
Examining the transcriptome we confirmed (Marks et al., 2012;
Yamaji et al., 2013; Leitch et al., 2013) substantial downregula-
tion of the two de novo methyltransferases Dnmt3a and Dnmt3b
and their regulator Dnmt3L in 2i (Figure 2B); in contrast, expres-
sion levels of the maintenance methyltransferase Dnmt1 and its
targeting factor Uhrf1 were not reduced (Figure 2B). DNA hy-
droxylase Tet2 levels were elevated consistently in 2i while
Tet1 and the lowly expressed Tet3 showed some variability
between different ESC lines (data not shown), but on the whole
they were not significantly altered (Figure 2B). These transcrip-
tional changes (together with changes in protein levels) occurred
within the first 24 hr of 2i addition (Figures 2C and 2D and data
not shown); considering this rapid decline we asked if downregu-
lated genes were direct targets of the Erk1/2 and Gsk3b path-
ways, similar to cMyc (a prototypical early response gene of
the Erk1/2 pathway). Dnmt3b plays a major role in de novo
methylation in the early embryo (Okano et al., 1999), therefore
we chose to focus on its regulation in 2i. Dynamic downregula-
tion of Dnmt3b mRNA occurred within 4–8 hr of 2i addition (but
not as fast as cMyc, which declines rapidly in 2i due to loss of
Erk signals driving cMyc transcription and rapid decay of preex-
isting cMyc mRNA; Figure 2C). DNMT3B protein levels declined
substantially 24 hr after 2i addition (Figure 2D) and were barely
detectable at later stages (the same was true of DNMT3A, data
not shown). Since transcriptional downregulation of Dnmt3b
was somewhat slower than that of cMyc, we considered the pos-
sibility that Dnmt3b silencing was carried out by a cis-acting
transcriptional regulator, and we therefore transfected a lucif-
erase expression construct driven by the Dnmt3b promoter
(including 8 kb of upstream sequence; Figure 2E) into serum or
2i cultured ESCs. We found that 2i caused a 5-fold reduction in
expression of luciferase compared to ESCs in serum (Figure 2F),
indicating that most of the transcriptional difference seen in vivo
(Marks et al., 2012; Yamaji et al., 2013; Leitch et al., 2013) reflects
signaling input into a cis-acting element. No difference in tran-
scription was seen between serum and 2i when a ±0.5 kb
(around the transciptional start site) Dnmt3b promoter region
was driving luciferase activity (Figure 2F). Candidates for regula-
tory sequences within the 8 kb transfected fragment include a
prominent cluster of enhancer hallmarks (DNaseI, H3K4me1,
H3K27ac, and p300) and binding of transcription factors Nanog
and Prdm14 upstream of the Dnmt3b promoter, with Prdm14
being highly upregulated in 2i cultured ESCs (Figures 2B and
2E). Notably, deletion of the Prdm14/Nanog binding region
reduced the difference in the response to serum versus 2i ofCell Sthe Dnmt3b construct by 50% (Figure 2F). This is consistent
with significant upregulation of Dnmt3b in Prdm14 knockout or
knockdown ESCs (Yamaji et al., 2013; Ma et al., 2011), and
furthermore with increased methylation in Prdm14 knockout
ESCs cultured in 2i (Yamaji et al., 2013; Leitch et al., 2013).
2i Demethylation Involves Oxidation, Replicative Loss,
and Repression of De Novo Methyltransferases
Given the rapid downregulation of Dnmt3b, Dnmt3a, and
Dnmt3L and increased expression of Tet2, we examined the pre-
cise dynamics of demethylation and hydroxymethylation from
the beginning of the 2i treatment. At the global level, methylation
decreased substantially in a stepwise manner during the first 24
and 72 hr after 2i addition, while during the same period there
was a more than 2-fold increase in hydroxymethylation (Fig-
ure 3A). This global increase in hydroxymethylation was transient
and declined in consecutive passages in parallel to the loss of
methylation. We next examined five individual genomic regions
that underwent substantial demethylation (>80%) and five con-
trol regions that were resistant to demethylation (including two
IAPs and two ICRs), analyzing in each case the levels of 5mC
and 5hmC at one MspI site (CCGG) at 24 hr, 72 hr, 7 days, and
11 days after 2i addition by glucosylation of genomic 5hmC
followed by methylation-sensitive qPCR (GlucMS-qPCR) (Fig-
ure 3B, Figure S2). In all demethylating regions there was a steep
loss of 5mC that occurred linearly during the early part of this
time period, with demethylation more or less completed 7 days
after 2i. Resistant regions experienced small losses of methyl-
ation during this period but stabilized during prolonged culture
in 2i. Notably, all regions that demethylated acquired substantial
levels of 5hmC (up to 40% resistance of the glucosylated DNA to
MspI digestion) with a peak at 72 hr after 2i, which then declined
together with 5mC, while regions that did not demethylate
acquired only minimal amounts of 5hmC (Figure 3B, Figure S2).
While expression levels of Dnmt1 (confirming Marks et al., 2012
and Leitch et al., 2013) and Uhrf1 were not reduced during 2i
induction, we wished to determine if maintenance of 5mC or
5hmC was nevertheless impaired in demethylating regions,
and thus carried out hairpin bisulphite and oxidative bisulphite
sequencing on LINE1 elements and on IAPs (Figure 3C, Fig-
ure S3). Hairpin bisulphite sequencing allows simultaneous ex-
amination of CpG methylation on both DNA strands (identifying
both fully and hemimethylated CpG dyads) while oxidative bisul-
phite sequencing discriminates between 5mC and 5hmC (Arand
et al., 2012) within the same CpG dyad. A maximum amount of
5hmCwas acquired by 72 hr after 2i at hemimodified CpG dyads
of LINE1Tf 50UTR (which demethylate) but not at IAPs (which
do not), consistent with reduced maintenance of both 5mC
and 5hmC in LINE1Tf (Figure 3C). A small amount of 5hmC accu-
mulated on fully modified CpGs in IAPs (also detected by
GlucMS-qPCR, Figure 3B) consistent with the mild erosion of
IAP methylation in 2i and potentially indicating a mechanism
whereby some of the 5hmC can be selectively ‘‘read’’ at replica-
tion as 5mC, a process that might be locus specific. Similar ob-
servations have been reported on ICRs and on loci escaping re-
programming in PGCs (Piccolo et al., 2013; Hackett et al., 2013).
The regulated hydroxylation during demethylation implicates
the Tet hydroxylases in this process; indeed, regions in the
genome that were most demethylated were enriched for Tet1tem Cell 13, 351–359, September 5, 2013 ª2013 The Authors 353
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Figure 2. Signaling and Transcriptional Regulation in 2i ESCs
(A) Comparison of promoter methylation levels with corresponding gene expression shows that in serum ESCs highly methylated genes are mostly underex-
pressed (blue group of gene promoters, blue histogram). In 2i (lower panel), there is no global change in the distribution of gene expression (see histograms on the
right hand side).
(B) Substantial downregulation of Dnmt3a, Dnmt3b, and Dnmt3L in ESCs cultured in 2i for 24 days as measured by RNA-seq (error bars represent the range of
values in two biological replicates). Transcription of maintenance methylation components Dnmt1 and Uhrf1 is not reduced, while Tet2 and Prdm14 expression
are upregulated in 2i ESCs.
(C) Timecourse of downregulation of Dnmt3b in 2i versus serum ESCs. Note the rapid downregulation of cMyc, a direct target of the Erk1/2 signaling pathway
(error bars represent the range of values in two biological replicates).
(D) DNMT3B protein levels at different time points after 2i addition with visible decrease at 24 hr after 2i.
(E) Dnmt3b upstream promoter genomic region shows PRDM14 and NANOG binding peaks overlapping putative enhancer elements. Shaded horizontal bars
indicate the constructs used in the luciferase assay in (F).
(F) Luciferase reporter assay with no promoter (pGL3-Basic) or the Dnmt3b promoter p3b 8615/+93 showing strong inhibition of luciferase expression in 2i.
Deletion of Prdm14 and Nanog binding sites (p3b8615/+93D) reduces repression in 2i by 50% (error bars represent the standard deviation of four independent
transfections for each plasmid in each condition, except the p3b500/+500 with two independent transfections).
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Rapid Demethylation to Ground State Epigenomebinding sites (Figure S1B). In order to eliminate most 5hmC in
ESCs, we knocked down Tet1 with siRNA in Tet2 knockout
ESCs, followed this with 2i treatment for 48 hr, and measured
5mC and 5hmC levels by GlucMS-qPCR. Loss of Tet1 and Tet2
resulted in substantial reduction of 5hmC acquisition in all deme-
thylating regions, and it delayed demethylation in 8 out of 13 re-
gions tested (Figure 3D). Preliminary results with individual Tet1
and Tet2 knockout ESCs subjected to 2i treatment suggest that
while hydroxylation is impaired in all demethylating regions, de-
methylation is impaired in some, but not in others (Figure 3E). In
order to expand this preliminary finding, more detailed genome-
wide analyses of methylation and hydroxymethylation at different
time points after 2i induction and upon manipulation of Tet1 and
Tet2 levelswill need to becarried out.Weconsidered the possibil-
ity that the rapid decline of the de novo methyltransferases
allowed the Tet enzymes increased access to the 5mC substrate;
however, combinedknockdownofDnmt3a,Dnmt3b, andDnmt3L
in serum/LIF cultured ESCs did not result in increased hydroxyl-
ation. While knockdown of Dnmt3 proteins led to demethylation
of LINE1Tf sequences, it had only mild effects on single copy
loci that demethylate in 2i (Figure S4), indicating that downregu-
lation of the de novo methyltransferases does not mimic the
methylation loss seen in the serum to 2i transition at all genomic
loci. Indeed, it hasbeenpreviously observed thatDnmt3a/Dnmt3b
double knockout ESCs lose global methylation slowly over
consecutive passages (Jackson et al., 2004; Arand et al., 2012),
while Dnmt3a and Dnmt3b are needed to maintain high levels of
methylation at LINE1s due to inefficient methylation maintenance
at these regions (Arand et al., 2012). It is possible that 2i treatment
causes increased accessibility of chromatin to Tet enzymes (Na-
kamura et al., 2012) and hence the substantial oxidation of DNA.
Heterogeneity in Serum ESCs Involves a Fluctuating
Epigenome
ESCs grown in serum show heterogeneous and dynamic expres-
sion of Nanog, Rex1, Stella, and other pluripotency-related
genes, while 2i ESCs express these genes more homogenously
(Chambers et al., 2007; Wray et al., 2010). A previous study
compared Rex1GFP-high and -low subpopulations from serum
ESCs, and found that, on a transcriptional level, the Rex1GFP-
high cells were more similar to ESCs grown in 2i (Marks et al.,
2012). We used fluorescence-activated cell sorting (FACS)
to isolate NanogGFP-high and -low subpopulations from a
NanogGFP (targeted Nanog-GFP clone A, or TNGA) ESC line.
We found that NanogGFP-high ESCs had elevated expression
of Prdm14 and Tet2 and reduced expression of Dnmt3b, in com-
parison toNanogGFP-low cells (Figure 3F).We examined several
loci that demethylate in 2i, and found that all of these had
increased hydroxylation and one-third had reduced methylation
in NanogGFP-high cells relative to NanogGFP-low cells (Fig-
ure 3G). This suggests that epigenetic fluctuations including
methylation and demethylation brought about by altered sig-
naling contribute to the metastable cell states in populations of
serumESCs.While NanogGFP-high ESCsdisplay transcriptional
and epigenetic similarities to ESCs grown in 2i, not surprisingly,
these two cell states are not exactly equivalent. Dnmt3L expres-
sion is reduced in 2i but elevated in NanogGFP-high ESCs (Fig-
ure 3F), and themagnitude ofmethylation changes in 2i is greater
than in the NanogGFP-high subpopulation (Figure 3G).Cell S2i Methylome Resembles that of ICM and
Migratory PGCs
Wenext asked towhat extent the epigenome in 2i ESCs reflected
that of early embryos. To do this, we compared our methylome
data sets to BS-seq from PGCs (Seisenberger et al., 2012) and
reduced representation bisulphite sequencing (RRBS-seq)
(Smith et al., 2012) from the early embryo (Figures 4A and 4B).
Because CGIs are overrepresented in RRBS-seq data, we
divided all data sets into a non-CGI and a CGI component, which
makes the two methods more comparable. For example, the
non-CGI component of RRBS-seq compared to BS-seq of
serum-grown ESCs shows very similar methylation levels in
various genomic elements (Figure 4A). Notably, methylation
levels of 2i ESCs at these same regions are highly similar to
those of ICM cells and E9.5 migratory PGCs, and hence distinct
from serum ESCs and epiblast on the one hand, and from
E13.5 gonadal PGCs on the other. The ICM, PGC, and 2i ESC
methylomes also closely resembled each other at the level of
CGIs: both showed greatly reduced numbers of methylated
CGIs compared to serum cultured ESCs and epiblast cells
(Figure 4B), further supporting the idea that epigenetically, 2i
ESCs are a model for preimplantation embryos (especially ICM)
and for migratory PGCs. A more detailed examination of the
methylation patterns in these CGIs revealed that while the
majority are demethylated, those CGIs that retained greater
than 25%methylation in 2i ESCs, PGCs, and ICM corresponded
to highly methylated CGIs from their cell type of origin (serum
ESCs, epiblast, and oocytes, respectively), a result illustrated
by hierarchical clustering of the data sets (Figure S1C). This
implies that any remaining qualitative differences between the
erased methylomes of 2i ESCs, PGCs, and ICM are related
to their developmental history as opposed to differences in
the mechanism by which they became demethylated. We
were unable to find any compelling transcriptomic similarities
between the three globally demethylated cell types (data not
shown). Global uncoupling of methylation and gene expression
is characteristic of PGCs (Seisenberger et al., 2012) and 2i
ESCs (Figure 2A) and apparently also true of the ICM. This
uncoupling thus seems characteristic of the epigenetic ground
state of pluripotency.
The globally hypomethylated state in 2i ESCs, PGCs, and ICM
is characterized by suppression of Dnmt3a, Dnmt3b, and
Dnmt3L (Figure 4C and Yamaji et al., 2013; Leitch et al., 2013).
Therefore in their simplest form the 2i-to-serum epigenetic tran-
sition is characterized by increased expression of Dnmt3b in
cells that express Nanog and Tet1. Can such a pattern be found
in the ICM to epiblast transition in vivo? In E3.5 ICM cells Tet1
and Nanog expression is indeed high while Dnmt3b is low,
whereas in the epiblast Dnmt3b is highly expressed while Tet1
and Nanog have been silenced (Tang et al., 2010). We therefore
examined E3.5 early, mid, and late blastocysts (depending
on their size and extent of cavitation) for NANOG, DNMT3B,
and TET1 expression by immunofluorescence (Figure 4D).
Early and mid E3.5 ICM cells that prominently express NANOG
and TET1 rarely express DNMT3B. A notable transition occurs
in late-stage ICM cells that now express DNMT3B prominently
together with moderately high TET1 and NANOG. Interestingly,
some NANOG-positive late ICM cells have lost high expression
of TET1, potentially indicating an early epigenetic change intem Cell 13, 351–359, September 5, 2013 ª2013 The Authors 355
(legend on next page)
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Figure 4. Global Hypomethylation in 2i
ESCs Resembles that of ICM Cells and
Migratory PGCs
(A) Global methylation levels in ESCs, ICM cells,
and PGCs from whole-genome BS-seq data
and reduced representation BS-seq (RRBS) data
sets (RRBS data are labeled with asterisk) (Sei-
senberger et al., 2012; Smith et al., 2012).
(B) Number of highly methylated (75%–100%) or
moderately methylated (50%–75%) CGIs of the
same samples in (A).
(C) Expression of de novo methyltransferases
Dnmt3a, Dnmt3b, Dnmt3L, and Myc in PGC E11.5
compared to E6.5 epiblast cells and ICM versus
ESCs (Tang et al., 2010; Seisenberger et al., 2012).
(D) E3.5 blastocysts stained for NANOG (red),
DNMT3B (green), and TET1 (white). Mouse E3.5
blastocysts were collected from CD1 3 CD1 and
(C57BL/6 3 CBA/Ca) 3 129/Sv crosses and were
classified as early, mid, or late E3.5, depending on
their size and extent of cavitation. Late blastocysts
show higher DNMT3B expression as well as a
greater proportion of ICM cells expressing both
NANOG and DNMT3B and slightly fewer NANOG-
and TET1-expressing cells (the number of Nanog-
positive cells counted from the total number of
embryos in parenthesis is shown below the
barplot). RGB profiles for representative ICM
(NANOG high) and outer trophectoderm (TE) cells
are shown for each stage.
(E) Model for 2i-mediated demethylation including
a peak of oxidation and reduced efficiency of
maintenance methylation and disruption of de
novo methylation.
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resemble 2i ESCs in their ground state epigenome, while later
stage ICM cells resemble serum ESCs before transiting to an
epigenetically primed epiblast cell type that is characterized by
high levels of Dnmt3b with Tet1 (and Tet2) being silenced
(Tang et al., 2010).Figure 3. Demethylation in 2i Involves Hydroxylation
(A) Mass spectrometric measurement of global 5mC and 5hmC levels in E14 (Day 24 Serum and 2i) and Tet1w
a stepwise decline of 5mC and a substantial transient increase in 5hmC.
(B) Absolute 5mC (blue) and 5hmC (red) levels in individual CpGs measured by GlucMS-qPCR validate the B
significantly hydroxymethylated after 2i addition with a peak at 72 hr. CpGs were selected according to the ex
demethylated in 2i (D1, D3, and D5).
(C) Hairpin bisulphite and oxidative bisulphite sequencing in LINE1Tf 50UTR at 24 hr, 72 hr, and 7 days after
through early demethylation phase with a 5hmC peak at 72 hr in LINE1Tf, but not IAP long terminal repeat 1
(D) GlucMS-qPCR in Tet2KOwith Tet1 knockdown ESCs shows increased 5mC levels 48 hr after 2i addition (b
targets) and virtually no 5hmC acquisition compared to the control (boxplot, red bars). Individual examples
(E) GlucMS-qPCR in Tet1wt versus Tet1/ and Tet2wt versus Tet2/ shows demethylation in someCpG site
(F) Gene expression measurement in NanogGFP sorted ESCs and similarities with 2i versus serum.
(G) GlucMS-qPCR in NanogGFP sorted ESCs. Error bars represent the range of values in two biological rep
See also Figures S2–S4.
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Work just published has shown that 2i
can induce global hypomethylation in
ESCs and that Dnmt3a, Dnmt3b, and
Dnmt3L and their regulation by Prdm14
is involved in this demethylation (Yamajiet al., 2013; Leitch et al., 2013). We have expanded on these
findings by carrying out genome-wide BS-seq and RNA-seq
studies and by examining the mechanisms of demethylation
and the resemblance of the reprogrammed state to PGCs,
ICM, and the subpopulation of serum ESCs that express high
levels of Nanog. The key conclusions from this work are thatt ESCs at 0, 24, and 72 hr after 2i addition showing
S-seq data and show that demethylating CpGs are
tent of demethylation: not demethylated (IAP1) and
2i addition showing the extent of hemimethylation
(IAPLTR1).
oxplot, blue bars, paired t test on 13 demethylating
are shown to the left.
s but significantly delayed demethylation in others.
licates throughout.
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pattern remarkably resembles the epigenomes of migrating
PGCs and of ICM cells in the blastocyst, with imprinted genes
being particularly resistant to erasure in all three systems. Hence
demethylation in imprinted ICRs can apparently be uncoupled
from genome-wide erasure of methylation.
Mechanistically, demethylation involves at least three compo-
nents, with Tet1 and Tet2 converting 5mC to 5hmC, together
with replicative loss of 5mC and 5hmC (Inoue and Zhang,
2011) or its further processing (Ito et al., 2011; He et al., 2011),
while at the same time de novo methylation is disabled (Fig-
ure 4E). Thesemechanistic components and associated charac-
teristic gene expression changes (Figure 2B and Figure 4C)
closely resemble those implicated in demethylation in migratory
PGCs (including cMyc, a signature response in 2i) and in preim-
plantation embryos (Seisenberger et al., 2012; Hackett et al.,
2013; Kagiwada et al., 2013; Piccolo et al., 2013; Grabole
et al., 2013). The 2i system therefore provides a convenient
model in which to study detailed interactions between these
mechanisms. As a demonstration of this, using luciferase assays
in 2i ESCs, we identified a cis-acting element that connects
changes in Erk1/2 and Gsk3b signaling with Dnmt3b expression
(Figures 2E and 2F), a mechanism likely to also be functional in
the ICM and PGCs.
In the ICM and in serum cultured ESCs, the two pluripotent cell
populations are short lived with rapid transitions between them
being intricately regulated by Erk1/2 and Gsk3b signaling and
the epigenetic networks described here, as well as the linked
pluripotency transcription factor network. Our findings establish
a signaling principle for the epigenetic ground state of pluripo-
tency in which Erk1/2 and Gsk3b signaling dynamically regulates
the DNA methylation machinery, with the combined effects of
downregulation of the de novo system and widespread DNA
hydroxylation destabilizing the maintenance system, leading to
inefficient propagation of DNA methylation and ultimately global
demethylation (Figure 4E).
EXPERIMENTAL PROCEDURES
Cell Lines, Culturing Conditions, and Blastocysts
E14, Tet1/, Tet1wt, Tet2/, and Tet2wt ESCswere cultured without feeders
either in standard serum-containing media (DMEM 4,500 mg/l glucose, 4 mM
L-glutamine, 110 mg/l sodium pyruvate, 15% fetal bovine serum, 1 U/ml
penicillin, 1 mg/ml streptomycin, 0.1 mM nonessential amino acids, 50 mM
b-mercaptoethanol, and 103 U/ml LIF ESGRO) or under 2i culturing conditions
(Ying et al., 2008) (serum-free N2B27 [Cat. DMEM/F12: GIBCO 21331; Neuro-
basal: GIBCO 21103; N2: Stem Cells SF-NS-01-005; B27: GIBCO 17504-044]
supplemented with 103 U/ml LIF and Mek inhibitor PD0325901 [1 mM] and
Gsk3b inhibitor CHIR99021 [3 mM]). NanogGFP (TNGA) ESCs (Chambers
et al., 2007) were cultured with feeders in standard serum-containing media.
FACS was performed after cells were stained with an antifeeder antibody
(Miltenyi Biotech) and DAPI on a BD FACSAria or BD Influx instrument. Mouse
E3.5 blastocysts were collected from CD13 CD1 and (C57BL/63 CBA/Ca)3
129/Sv crosses.
DNA/RNA Extraction and RNA-seq and BS-seq Library Preparation
Genomic DNA was prepared using QIAamp DNA Micro Kit or AllPrep DNA/
RNA mini kit (QIAGEN). RNA was extracted using either the AllPrep DNA/
RNA mini kit or RNeasy mini kit (QIAGEN) and subjected to DNAase treatment
using the Ambion DNA-free kit according to the manufacturers’ instructions.
mRNA library preparation for RNA-seq was done as previously described
(Ficz et al., 2011). For BS-seq library preparation DNA samples were frag-358 Cell Stem Cell 13, 351–359, September 5, 2013 ª2013 The Authmented by sonication (Covaris) and adaptor ligated (using Illumina supplied
methylated adaptors and NEBnext library preparation kit). Subsequently,
DNA was bisulphite-treated using the Sigma Imprint kit, according to the
manufacturer’s instructions (one step protocol). Final library amplification
(16 cycles) was done using Pfu Turbo Cx (Agilent), after which the libraries
were gel-purified using QIAGEN Minelute kit.
GlucMS-qPCR Assay
Preparation of gDNA for GlucMS-qPCR assay was done as described previ-
ously with modifications (Ficz et al., 2011). Briefly, 250 ng of genomic DNA
was treated with T4 Phage b-glucosyltransferase (NEB M0357S) according
to the manufacturer’s instructions. Seventy nanograms of glucosylated
gDNAwere digested with 10 U of HpaII or MspI or no enzyme (mock digestion)
at 37C for 2 hr, then inactivated for 20min at 80C. The HpaII- andMspI-resis-
tant fraction was quantified by qPCR using primers designed around a single
HpaII/MspI site, normalizing to the mock digestion control (Table S2).
DNA Sequencing
Libraries were sequenced on either an Illumina GAIIx or an Illumina HiSeq
using the default RTA analysis software. See Table S1 for the outcomes of
the sequencing runs.
ACCESSION NUMBERS
Raw data from all libraries was deposited with GEO under the accession
GSE42923.
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